Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction.
Lønborg J, Vejlstrup N, Kelbæk H, Bøtker HE, Kim WY, Mathiasen AB, Jørgensen E, Helqvist S, Saunamäki K, Clemmensen P, Holmvang L, Thuesen L, Krusell LR, Jensen JS, Køber L, Treiman M, Holst JJ, Engstrøm T.
Lønborg J, et al. Among authors: vejlstrup n.
Eur Heart J. 2012 Jun;33(12):1491-9. doi: 10.1093/eurheartj/ehr309. Epub 2011 Sep 14.
Eur Heart J. 2012.
PMID: 21920963
Clinical Trial.